Conversely, DDX5 downregulates NRGN, a gene crucial for synaptic plasticity and often associated with neurological and mental disorders, particularly Alzheimer’s disease, where it serves as a reliable biomarker for synaptic dysfunction157. The gene discussed is NRGN; the disease is Alzheimer disease.